Synergistic effect of MTHFR C677T and F2 G20210A polymorphisms on ischemic stroke

被引：6
|
作者：
They-They, Thierry Paluku [1 ,2 ]
Battas, Omar [1 ]
Nadifi, Sellama [2 ]
机构：
[1] Hassan II Univ, Fac Med, Dept Clin Neurosci & Biol Psychiat, Casablanca 10000, Morocco
[2] Hassan II Univ, Lab Genet & Mol Pathol, Fac Med, Casablanca 10000, Morocco
来源：
NEUROSCIENCE BULLETIN | 2013年 / 29卷 / 06期
关键词：
genotyping; prothrombotic polymorphisms; risk factor; MTHFR; F2; stroke; FACTOR-V-LEIDEN; METHYLENETETRAHYDROFOLATE REDUCTASE; YOUNG-ADULTS; PLASMA HOMOCYSTEINE; PROTHROMBIN G20210A; RISK-FACTOR; MYOCARDIAL-INFARCTION; COMMON MUTATION; DISEASE; GENE;
D O I：
10.1007/s12264-013-1381-4
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
The predisposition to stroke might involve interactive effects among variants in several genes. We tested this hypothesis by examining the influence of polymorphisms in methylenetetrahydrofolate reductase (MTHFR) (C677T) and prothrombin (F2) (G20210A) as risk factors for stroke in Morocco. The polymerase chain reaction-restriction fragment length polymorphism methods were used to analyze DNA from 91 stroke patients and 182 controls. Association between the two polymorphisms and the risk of stroke was estimated by four-level models for the analysis of genetic interaction. Neither the MTHFR 677TT nor the F2 20210GA genotype showed any significant association compared to the MTHFR CC and F2 GG genotypes, respectively. An interactive effect between the MTHFR 677TT and F2 20210GA polymorphisms showed an increased risk of stroke. The odds ratios, in univariate and multivariate analysis, for the combined polymorphisms were 4.99 (95% CI, 1.75-14.2, P = 0.001) and 5.29 (95% CI, 1.63-17.1, P = 0.005), respectively.
引用
收藏
页码：725 / 730
页数：6
相关论文
共 50 条
  • [31] LEIDEN FV, PT G20210A Y MTHFR C677T MUTATIONS FREQUENCY IN MEXICAN PATIENTS WITH PRIMARY TROMBOPHILIA
    de la Luz Arenas-Sordo, Maria
    Zavala-Hernandez, Cesar
    Hernandez-Zamora, Edgar
    Martinez-Murillo, Carlos
    Majluf-Cruz, Abraham
    Reyes-Maldonado, Elba
    Vela-Ojeda, Jorge
    IUBMB LIFE, 2009, 61 (03) : 326 - 327
  • [32] Methylenetetrahydrofolate reductase gene polymorphisms are associated with ischemic and hemorrhagic stroke: Dual effect of MTHFR polymorphisms C677T and A1298C
    Sazci, Ali
    Ergul, Emel
    Tuncer, Nese
    Akpinar, Gurler
    Kara, Ihsan
    BRAIN RESEARCH BULLETIN, 2006, 71 (1-3) : 45 - 50
  • [33] Prevalence of F5 1691G>A, F2 20210G>A, and MTHFR 677C>T polymorphisms in Bosnian women with pregnancy loss
    Mahmutbegovic, Emir
    Marjanovic, Damir
    Medjedovic, Edin
    Mahmutbegovic, Nevena
    Dogan, Serkan
    Valjevac, Amina
    Czerska, Ewa
    Pawinska-Matecka, Anna
    Madlani, Agnieszka
    Adler, Grazyna
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2017, 17 (04) : 309 - 314
  • [34] Prevalence of prothrombin (G20210A) and methylenetetrahydrofolate reductase (C677T) gene polymorphisms in central retinal vein occlusion
    Hykin, PG
    Sherafat, H
    Boyd, S
    Gin, T
    Owens, D
    Perry, D
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S708 - S708
  • [35] Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke
    Lopaciuk, S
    Bykowska, K
    Kwiecinski, H
    Mickielewicz, A
    Czlonkowska, A
    Mendel, T
    Kuczynska-Zardzewialy, A
    Szelagowska, D
    Windyga, J
    Schröder, W
    Herrmann, FH
    Jedrzejowska, H
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2001, 7 (04) : 346 - 350
  • [36] Effect of MTHFR C677T on homocysteine and folate levels in young ischemic stroke patients
    Mbarek, I.
    Sakka, S.
    Megdich, F.
    Naeifer, M.
    Dammak, M.
    Ayedi, F.
    Kallel, C.
    Mhiri, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 754 - 754
  • [37] Evaluation of the role of three thrombophilic mutations (FV Leiden, prothrombin G20210A and MTHFR C677T) in recurrent fetal losses
    Foka, Z
    Lambropoulos, A
    Saravellos, C
    Agorastos
    Zournatzi, V
    Bontis, J
    Makris, PE
    Kotsis, A
    THROMBOSIS AND HAEMOSTASIS, 1999, : 643 - 643
  • [38] FV LEIDEN, FII G20210A AND MTHFR C677T MUTATIONS IN PATIENTS WITH LOWER OR UPPER LIMB DEEP VEIN THROMBOSIS
    Djordjevic, Valentina
    Pruner, Iva
    Rakicevic, Ljiljana
    Kovac, Mirjana
    Mikovic, Danijela
    Miljic, Predrag
    Antonijevic, Nebojsa
    Radojkovic, Dragica
    GENETIKA-BELGRADE, 2011, 43 (02): : 371 - 380
  • [39] Factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms and the risk of tamoxifen-associated thromboembolism in breast cancer patients
    Eroglu, Aydan
    Akar, Nejat
    THROMBOSIS RESEARCH, 2011, 127 (04) : 384 - 385
  • [40] EXPERIENCES IN SIMULTANEOUS DETECTION OF FACTOR V LEIDEN, FACTOR II G20210A, MTHFR C677T AND MTHFR A1298C MUTATIONS IN PATIENTS WITH THROMBOPHILIA
    Beletic, A.
    Djordjevic, V.
    Canic, I.
    Kocica, T.
    Kuzmanovic, I.
    Golubovic, M.
    Mirkovic, D.
    Radojkovic, D.
    Majkic-Singh, N.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S599 - S599
12345